Cargando…
Defining the Mycobiome in Bladder Cancer
Autores principales: | Mercier, Benjamin D., Castro, Daniela V., Pal, Sumanta K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9807994/ https://www.ncbi.nlm.nih.gov/pubmed/36606201 http://dx.doi.org/10.1016/j.euros.2022.11.023 |
Ejemplares similares
-
Sex-specific Augmentation of Treatment Responses in Bladder Cancer
por: Chang, Kevin, et al.
Publicado: (2022) -
Early or Delayed Radical Cystectomy for High-risk Non–muscle-invasive Bladder Cancer: A Hard Dilemma to Solve
por: De Nunzio, Cosimo, et al.
Publicado: (2022) -
Checklist for Transurethral Resection of Bladder Tumor (TURBT): A Step Forward in the Standardization for TURBT Reporting
por: Martínez-Piñeiro, Luis
Publicado: (2022) -
Abandon the Label of Clinically Insignificant Prostate Cancer
por: Mertens, Laura S., et al.
Publicado: (2022) -
Prostate Cancer Diagnosis Without Histological Proof: Is Treating Images Reasonable?
por: Rouvière, Olivier, et al.
Publicado: (2022)